About Us

Management Team

Monitored Therapeutics is led by a  team of seasoned professionals who are experienced in changing healthcare delivery.

Chief Executive Officer

Michael Taylor is a senior medical device professional with over 18 years of public and private company experience in many aspects of business including strategic planning, business development, product management, project management, clinical services, marketing and customer care.  He has worked with many medical device companies and is the former Senior Director, Healthcare Solutions at eResearch Technology.  Prior to ERT he held multiple Director level roles at VIASYS, Cardinal Health and CareFusion. He graduated from the University of Toledo with a BS in Exercise Science and completed coursework for MS in Exercise Physiology.

Chief Science Officer

Alex Stenzler, (President, 12th Man Technologies) was the former VP Advanced Technologies for CareFusion Inc, (VIASYS, Cardinal Health). Mr. Stenzler brings more than 30 years of clinical and commercial experience in pulmonary medicine to his position. Mr. Stenzler has also held several academic appointments, including Assistant Professor at the State University of New York at Stonybrook and twelve years at the Graduate School of Adelphi University. He has been the principal investigator for various NIH and DARPA studies, and served on steering committees for randomized controlled trials in high-frequency ventilation, inhaled nitric oxide and liquid ventilation. He has published numerous papers and abstracts and has been an invited speaker at many national and international congresses. He also holds more than 35 US patents for various technologies.

Chief Operating Officer

Jim Kamnikar has over 20 years of experience in operations, ecommerce, product development, digital marketing, and business strategy.  He was CEO of GoAntiques, Inc. until its acquisition by Worthpoint Corporation in 2008. At GoAntiques he provided the leadership and strategy that grew the Company’s ecommerce platform to over 1,800 vendors in 36 countries. He co-founded Seen Digital Media, whose social intelligence platform brought together top creators, brands and fans through innovative social media content. Seen customers included Ford, Pepsi, AT&T, Reebok, Hilton, and Hershey’s.  Seen was acquired by ICX Media in May 2018. 

Chief Regulatory Officer

Barry Sugarman is a Senior Pharmaceutical and Medical Device Executive with over 30 years of public and private company experience in all aspects of business including domestic and international management, strategic planning, manufacturing, product development, quality control, quality assurance, Good Manufacturing Practices (GMP’s), Good Clinical Practices (GCP’s), Good Laboratory Practices (GLP’s), regulatory affairs operations, engineering, new business development, marketing, and distribution. Experience includes mergers, startups, reorganization, process improvements, and sales management. Licenses: California Board of Pharmacy, Supervisor of Pharmaceutical Manufacturing or Wholesale Operations.

Board of Directors


William “Bill” Ross began his 30-year career in healthcare technology as an executive for SensorMedics Critical Care. Initially involved in the sales and marketing of their respiratory care product lines, he later drove major business development efforts and guided several key acquisitions in the U.S. and Europe. Ascending to the position of president, he shepherded the organization through acquisitions by Thermo Electron and the subsequent spin-off of VIASYS Healthcare, where he served as interim CEO and later COO.

Mr. Ross holds a B.S. in electrical engineering from the University of Idaho, and an M.S. in biomedical engineering from Washington University. Prior to joining SensorMedics he worked on nuclear medicine imaging technology and electronic circuitry development for the automotive industry.

He currently serves on the board of directors of several privately held corporations.


Board Member

Steven Han is Vice President of 12th Man Technologies – Steve brings more than 20 years of product development in medical and consumer products. He has worked with many medical companies such as CareFusion (formally Cardinal Health), Johnson and Johnson, Abbott Laboratories, and Philips (formally Respironics). He has extensive experience with both R&D, product development, manufacturing, designing equipment and assemblies, as well as injection molding for plastic and silicone. He has 22 US patents and 10 patents pending. He graduated with Provost Honors at University of California, San Diego with a BS in Mechanical Engineering.

Co-Founder and Board Member

William Zimlich is the former CEO of Activaero America, Inc., a pulmonary drug delivery technology company specializing in severe lung diseases that was acquired in 2014 by Vectura Group.  Prior to joining Activaero, Mr. Zimlich was Vice President of Product Development for BattellePharma, a spin-off from Battelle Memorial Institute.  Bill co-founded the company on two technologies of which he was the lead inventor; Inhaled Chemotherapy and Electrohydrodynamics for Pulmonary Drug Delivery.  Before BPT, Bill worked for Battelle as a Program Director in Medical Product Development with clients such as Invacare, Johnson and Johnson, Abbott and Bristol Myers Squibb.  Subsequent to Battelle, Bill worked managerial, engineering, marketing and manufacturing roles for both large and small medical device companies.  Bill is published in Books, Journals and Encyclopedias on the subject of Pulmonary Drug Delivery.  He has over a dozen patents and pending patents.  He holds an engineering degree from The Ohio State University.

Board Members (bios above)

Alex Stenzler

Michael Taylor

Barry Sugarman